Medical consumables national brand opportunities coming?
The company's main business is to promote the use of medical supplies, and to promote the use of medical supplies. The Measures require that when medical institutions purchase medical equipment, they should fully consider the cost of supporting the use of medical consumables, and take it as an important reference factor for the purchase of medical equipment.
A domestic medical device company executives told reporters that this is both an opportunity and a challenge for domestic medical device companies. In the case of medical institutions to reduce procurement costs, the original high price of imported consumables is expected to be replaced by low-priced, good quality domestic consumables, which is an opportunity. However, the challenges faced by the industry as a whole should not be underestimated. Combined with the previous policies such as the sunshine procurement of consumables, the overall medical device industry is under pressure to reduce prices, and enterprises need to change the original distribution chain and sales model.
2026-08-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Egyptian Pharmaceutical Market Research
-
CPHI China 2023 | At the Heart of Pharma
-
A Guide Into What the Pharmaceutical Use of Hexamine Is
-
In line with the 8201, Hengrui Pharmaceutical plans the HER2 ADC in this way
-
$50 billion in products were 'returned' to rationalize those blockbuster BD deals
-
Tronsound long-acting IL-36R antibody obtained FDA clinical IND
-
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
-
The FDA accepted Zuranolone's NDA application and granted it priority review rights for the treatment of MDD and PDD
-
Asia Hong Pharma announced that it has co-developed an innovative tumor therapy based on AI+RNA technology route with ReviR
-
Ribo Biologics announced that the world's first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia
Recommend Reading
-
Three Major Indian Chemical Investments Target China's PC Exports
-
West Asia Tensions Squeeze Pharma Raw Materials
-
Iran Closes Strait of Hormuz to All Vessels: Global Chemical Trade Gets Choked
-
U.S. Onshoring Debate Exposes API Raw-Material Gap
-
Pharmaceutical Tariffs Put Ingredients Back in Focus
-
Business Society’s Market Outlook for Fuel Oil 180CST on August 10, 2026: Volatile
-
This week, China's acetone market continues to weaken
-
Business Society’s Diesel Market Outlook on August 10, 2026: Volatile but Rising
-
In the second half of April, the butadiene rubber market in China showed a slight decline
-
Ethanol Market Conditions Show Signs of Recovery
- Hot Searches
- dimethyl carbonate price
- where can i buy reta peptide
- medetomidine for sale
- ammonium bisulfate
- best research chemical sites
- cosmetic raw material suppliers
- chemical compound of acetone
- research chem sites
- carbon tetrabromide
- map fertilizer price
- retatrutide peptide supplier
- benzene prices